HUP1100241A3 - Oxetane substituted pyrimidones - Google Patents

Oxetane substituted pyrimidones

Info

Publication number
HUP1100241A3
HUP1100241A3 HU1100241A HUP1100241A HUP1100241A3 HU P1100241 A3 HUP1100241 A3 HU P1100241A3 HU 1100241 A HU1100241 A HU 1100241A HU P1100241 A HUP1100241 A HU P1100241A HU P1100241 A3 HUP1100241 A3 HU P1100241A3
Authority
HU
Hungary
Prior art keywords
oxetane substituted
substituted pyrimidones
pyrimidones
oxetane
substituted
Prior art date
Application number
HU1100241A
Other languages
Hungarian (hu)
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Priority to HU1100241A priority Critical patent/HUP1100241A3/en
Priority to PCT/HU2012/000032 priority patent/WO2012153154A1/en
Publication of HUP1100241A2 publication Critical patent/HUP1100241A2/en
Publication of HUP1100241A3 publication Critical patent/HUP1100241A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
HU1100241A 2011-05-06 2011-05-06 Oxetane substituted pyrimidones HUP1100241A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1100241A HUP1100241A3 (en) 2011-05-06 2011-05-06 Oxetane substituted pyrimidones
PCT/HU2012/000032 WO2012153154A1 (en) 2011-05-06 2012-05-04 Oxetane substituted thieno pyrimidinones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1100241A HUP1100241A3 (en) 2011-05-06 2011-05-06 Oxetane substituted pyrimidones

Publications (2)

Publication Number Publication Date
HUP1100241A2 HUP1100241A2 (en) 2012-12-28
HUP1100241A3 true HUP1100241A3 (en) 2013-12-30

Family

ID=89990277

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1100241A HUP1100241A3 (en) 2011-05-06 2011-05-06 Oxetane substituted pyrimidones

Country Status (2)

Country Link
HU (1) HUP1100241A3 (en)
WO (1) WO2012153154A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014127214A1 (en) * 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
ES2913423T3 (en) * 2016-02-12 2022-06-02 Cytokinetics Inc Tetrahydroisoquinoline derivatives
CN113045523B (en) * 2019-12-27 2022-09-23 上海泓博智源医药股份有限公司 Preparation method of imidazoline pyridine compound intermediate

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1169027A (en) 1966-11-19 1969-10-29 Beecham Group Ltd Azetidine Derivatives
GB0124627D0 (en) 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
CA2521832A1 (en) 2003-04-11 2004-10-28 Smithkline Beecham Corporation Heterocyclic mchr1 antagonists
CN1871242A (en) 2003-10-23 2006-11-29 葛兰素集团有限公司 3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety
WO2005047293A1 (en) 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
US7989445B2 (en) 2005-04-28 2011-08-02 Takeda Pharmaceutical Company Limited Thienopyrimidone compound
WO2007011284A1 (en) 2005-07-15 2007-01-25 Astrazeneca Ab Therapeutic agents
WO2007011286A1 (en) 2005-07-15 2007-01-25 Astrazeneca Ab Therapeutic agents
AR056155A1 (en) 2005-10-26 2007-09-19 Bristol Myers Squibb Co ANTAGONISTS OF NON-BASIC MELANINE CONCENTRATION HORMONE RECEIVER 1
US7745447B2 (en) 2005-10-26 2010-06-29 Bristol-Myers Squibb Company Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
TW200800920A (en) 2006-02-15 2008-01-01 Sanofi Aventis Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
CN101384605A (en) 2006-02-15 2009-03-11 塞诺菲-安万特股份有限公司 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
US20070299062A1 (en) 2006-06-26 2007-12-27 The Procter & Gamble Company Melanin concentrating hormone antagonists
WO2008020799A1 (en) 2006-08-18 2008-02-21 Astrazeneca Ab Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists
EP2148931A2 (en) 2007-04-17 2010-02-03 Vertex Pharmaceuticals Incorporated Drug discovery methods for aurora kinase inhibitors

Also Published As

Publication number Publication date
HUP1100241A2 (en) 2012-12-28
WO2012153154A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
HK1203196A1 (en) Substituted benzylpyrazoles
HK1197063A1 (en) Heterocyclyl aminoimidazopyridazines
DK3424953T3 (en) Terapeutiske antistoffer
EP2790561A4 (en) Dishmachine
EP2755962A4 (en) Azaindazoles
EP2715659A4 (en) Überfeed
EP2754063A4 (en) Smb2 scaleout
EP2776444A4 (en) Dihydropteridinones
EP2723631A4 (en) Quadfolier
AP2014007621A0 (en) 2-Thiopyrimidinones
EP2658720A4 (en) Printing
EP2663331A4 (en) Novel uses
EP2695208A4 (en) Micro-thermocouple
EP2758058A4 (en) Substituted pyrimidines
EP2679138A4 (en) Endsoscope
EP2758059A4 (en) Substituted pyrimidines
EP2708561A4 (en) Bio-pin
GB201119167D0 (en) Novel bachteriophages
DK2770906T3 (en) Applanationstonometer
EP2684382A4 (en) Earpuff
IL227377A0 (en) Combinations
HUP1100241A2 (en) Oxetane substituted pyrimidones
EP2698098A4 (en) Campimeter
EP2694655A4 (en) pAVEC
GB201107672D0 (en) Ink

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished